United States · FDA National Drug Code directory
Carbidopa and Levodopa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69367-340_62a61a12-9747-4739-abd1-106a2375b0f7
- Product NDC
- 69367-340
- Form
- TABLET
- Composition / generic term
- Carbidopa and Levodopa
- Labeler
- Westminster Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210930
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 25 mg/1
- LEVODOPA — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (69367-340-01) · 69367-340-01
- 500 TABLET in 1 BOTTLE, PLASTIC (69367-340-05) · 69367-340-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →